ClearPoint Neuro, Inc.

04/29/2026

Neuro to Announce First Quarter 2026 Results May 13, 2026 - Read More Here: https://loom.ly/RTKr-sw

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 April 29, 2026 4:05pm EDT Download as PDF SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigat...

04/29/2026

The countdown to is underway, and Neuro is excited to connect with the neurosurgical community and share recent advancements across our portfolio.

ClearPoint Neuro's first-ever Peers & Perspectives educational event - taking place the evening of May 2nd and featuring words from Drs. Nick Brandmeir and Paul Larson - is nearing capacity. For physicians interested in attending, we encourage you to visit Booth #703 or reach out to a local ClearPoint Neuro representative to request an invitation. We look forward to seeing you in San Antonio!

04/22/2026

Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Read More Here: https://loom.ly/xQiJIBI

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint April 22, 2026 4:05pm EDT Download as PDF SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint....

04/20/2026

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Read More Here: https://loom.ly/Ybt5_qc

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint April 20, 2026 4:05pm EDT Download as PDF Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage th...

04/17/2026

Neuro is looking forward to once again hosting the annual IGNITE Summit bridging together international experts in nervous system drug delivery, neurological disorders, functional neurosurgery, and coding/reimbursement as well as industry representatives. Our current portfolio of biopharma development programs now includes 60+ partners with over 25 clinical trials actively enrolling patients across the United States today. As with every year, our goal is to do our part in supporting the possibility of wide spread adoption and patient access to care through scalable delivery platforms and exceptional support in the field.

03/17/2026

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results - Read More Here: https://loom.ly/s_IuG8s

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results March 17, 2026 4:05pm EDT Download as PDF Related Documents Earnings Webcast Audio Record Revenue and IRRAS Holdings Acquisition Highlight the Company's 'Fast. Forward.' Strategy SOLANA BEACH, CA / ACCESS Newswire / March 17, 2026 /....

03/06/2026

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 - Read More Here: https://loom.ly/6PEymZc

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 March 06, 2026 8:00am EST Download as PDF SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering...

02/02/2026

Neuro is starting 2026 strong with a team of over 170 people focused entirely on Neuro. We’re excited to keep this momentum going and see what we can achieve together!

01/22/2026

Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe - Read more here: https://loom.ly/EfJuDX0

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe January 22, 2026 4:30pm EST Download as PDF SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro,....

01/20/2026

Neuro was excited to take part in the recent Neurosurgery Research Consortium. Our new Chief Medical Officer - Dr. Paul Larson - got a chance to share his vision for advancing our Biologics and Drug Delivery development programs.

11/20/2025

ClearPoint Neuro Completes Acquisition of IRRAS - Read more here: https://loom.ly/ualabV8

ClearPoint Neuro Completes Acquisition of IRRAS November 20, 2025 5:00pm EST Download as PDF Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire / Novem...

11/06/2025

ClearPoint Neuro Reports Third Quarter 2025 Results - Read More Here: https://loom.ly/8gwEkRA

ClearPoint Neuro Reports Third Quarter 2025 Results November 06, 2025 4:55pm EST Download as PDF Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later Commercialization SOLANA BEACH, CA / ACCESS Newswire /....